Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.91 USD | +0.89% | +8.59% | -19.05% |
Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.05% | 1.87B | |
-2.29% | 103B | |
+0.96% | 95.71B | |
+1.89% | 22.02B | |
-16.52% | 20.9B | |
-9.16% | 17.85B | |
-42.83% | 16.21B | |
-14.89% | 15.52B | |
+3.56% | 13.86B | |
+33.31% | 12.04B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals : Earnings Flash (RXRX) RECURSION PHARMACEUTICALS Posts Q1 Revenue $2.6M